|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 445 of 476 found articles
| Title: |
185 (PB173): The novel peptide drug conjugate AVA6103 is a FAP-enabled preCISION™ medicine which targets Topoisomerase I to the tumor microenvironment via FAP cleavage |
| Author: |
Watts, E. Rink, C. Orafidiya, F. Lahu, G. Jones, D. Wilson, F. |
| Appeared in: |
European journal of cancer |
| Paging: | Volume 211 () nr. S1 pages p. |
| Year: |
2024 |
| Contents: | |
| Publisher: |
Elsevier LTD. All rights reserved. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 445 of 476 found articles
| << previous | next >> |